| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8230189 | International Journal of Radiation Oncology*Biology*Physics | 2011 | 8 Pages |
Abstract
Postradiation metabolic tumor volume is an adverse prognostic factor in head-and-neck cancer. Biomarkers such as MTV are important for risk stratification and will be valuable in the future with risk-adapted therapies.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
James D. M.D., Trang H. M.D., Karen M.D., Andrew M.D., Nancy J. M.D., Peter G. Ph.D., Edward E. Ph.D., Billy W. M.D., Ph.D., Quynh-Thu M.D.,